Fondazione Policlinico Universitario Agostino Gemelli-ISTITUTO DI EMATOLOGIA ( Site 0383)

Rome, Lazio 00168

0 studies enrolling now · 1 studies all time

What they study most

Hematological Malignancies

Studies at this site

• A Study of Pembrolizumab/Vibostolimab (MK-7684A) in Relapsed/Refractory Hematological Malignancies (MK-7684A-004, KEYVIBE-004) — Completed